Kineta, Inc. Common Stock
KA
KA: Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.
moreShow KA Financials
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of KA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by KA's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on KA's company Twitter account
WallStreetBets
Number of mentions of KA in WallStreetBets Daily Discussion
KA News
Recent insights relating to KA
CNBC Recommendations
Recent picks made for KA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in KA
Corporate Flights
Flights by private jets registered to KA